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Mouse epidermal cytosol contains a protein phosphatase with M, 38000, which dephosphorylates the elongation factor 2 (EF-2) of protein biosyn- 
thesis and is stimulated after topical application of TPA to mouse skin [(1988) Biochem. Biophys. Res. Commun. 153, 1129-I 1351. Dephosphoryla- 
tion of EF-2 by this phosphatase is inhibited by okadaic acid at concentrations as low as 10m8 M, but not by heparin up to concentrations of 
600 &ml. The catalytic subunit of protein phosphatase 2A (PP2AJ with EF-2 as a substrate xhibits the same sensitivity towards okadaic acid 
and insensitivity towards heparin as the EF-2 phosphatase of epidermal cytosol. The catalytic subunit of protein phosphatase 1(PPl,) is strongly 
suppressed by heparin and less sensitive towards okadaic acid than PP2&. PP2& is around 50 times more efficient in dephosphorylating EF-2 
than PPI,. These data indicate that the TPA-stimulated EF-2 phosphatase in epidermal cytosol is a type 2A protein phosphatase. 
Protein biosynthesis; Elongation factor 2; Protein phosphatase; Okadaic acid; Heparin 
1. INTRODUCTION 
Phosphorylation and dephosphorylation of the 
elongation factor 2 (EF-2) appears to play a major role 
in the regulation of protein biosynthesis. EF-2 is 
phosphorylated by the Ca’+/calmodulin-dependent 
kinase III very selectively [l-4]. As yet no other 
substrate of this kinase has been found. Rapid and 
transient phosphorylation of EF-2 is observed after ap- 
plication of mitogens to cultured cells [5]. The role of 
this EF-2 phosphorylation is rather mysterious, 
especially since phosphorylated EF-2 was shown to be 
inactive in the elongation process [2,6]. Thus, 
dephosphorylation of EF-2 should be expected to 
follow the brief pulse of phosphorylation and to be 
essential for stimulation of protein synthesis. Indeed, 
we have shown recently that topical application of the 
tumor-promoting phorbol ester, TPA, to mouse skin 
stimulates the activity of an EF-2 phoshatase in epider- 
ma1 cytosol [7] as well as epidermal protein synthesis 
[3]. This protein phosphatase or at least its catalytic 
subunit was found to have IV, ~38000 [7] indicating the 
identity with a type 1 or a type 2A phosphatase. 
Here we show that the purified catalytic subunit of 
protein phosphatase 2A (PP2A,) is much more efficient 
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in dephosphorylating EF-2 than that of protein 
phosphatase 1 (PPl,). Furthermore, the TPA- 
stimulated EF-2 phosphatase in mouse epidermis 
cytosol can be inhibited by okadaic acid at concentra- 
tions as low as lo-’ M, but not by heparin, also in- 
dicating that the EF-2 phosphatase is a type 2A protein 
phosphatase. 
2. MATERIALS AND METHODS 
2.1. Materials 
12-0-Tetradecanoylphorbol-13-acetate (TPA) and okadaic acid 
were kindly supplied by Professor Dr E. Hecker, German Cancer 
Research Center, Heidelberg, FRG and by Professor Dr O.-G. Iss- 
inger, University of Saarland, Homburg, FRG, respectively. 
[T-~*P]ATP (spec. act. 3000 Ci/mmol) was from New England 
Nuclear (Waltham, MA, USA). Heparin was from Roth (Karlsruhe, 
FRG). 
2.2. Methods 
The keeping of animals and the following procedures were per- 
formed as described previously [3,7,8]: preparation of cytosol from 
mouse epidermis and from mouse pancreas, polyacrylamide gel elec- 
trophoresis and autoradiography. 
2.2.1. Purification of protein phosphatases 
The catalytic subunits of protein phosphatase 1 (PPl,) and 2A 
(PPZA,) were purified from rabbit muscle according to Tung et al. 
191. 
2.2.2. Assay for protein phosphatases 
The activity of the purified enzymes was determined with 32P- 
labelled phosphorylase a as a substrate. Phosphorylase a was 
phosphorylated with phosphorylase kinase and [y-32P]ATP as 
described previously [lo]. The reaction mixture of the phosphatase 
assay contained 10 ~1 of an assay mixture (200 mM Tris-HCl, pH 7.4, 
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0.1% (v/v) mercaptoethanol, 1 mg/ml bovine serum albumin), 38 pl 
of the enzyme preparation or buffer alone and 2&l 
[32P]phosphorylase a. The reaction was started by the addition of the 
labelled phosphorylase a and, after an incubation at 30°C for 5 min, 
it was stopped by adding 20 pl of trichloroacetic acid (25%, w/v) and 
20~1 of bovine serum albumin, potassium phosphate (1 mg/ml, 
0.5 M, pH 7.0). After centrifugation, radioactivity of the 
precipitated protein as well as of an aliquot of the supernatant was 
counted. One unit of phosphatase activity is defined as 1 nmol 
phosphate liberated per min under the assay conditions. 
2.2.3. Assay for the EF-2 dephospho~Iating activity of epidermal 
cytosol 
The assay was performed essentially as described previously [7]. 
Proteins of pancreas cytosol were phosphorylated with [32P]ATP at 
30°C for 4 min as described previ&sly IS]. 20 pl of phosphorylated 
pancreas cytosol were mixed with 30 pf of epidermal cytosol of mice, 
which had received a topical application of 10 nmol TPA for 17 h. 
The mixture was incubated at 30°C for 15 min. In some experiments, 
okadaic acid or heparin was added to the incubation mixture as in- 
dicated in the text. The reaction was stopped by the addition of ice- 
cold 10% trichloroacetic acid. The following treatment of the 
samples for the separation of phosphorylated proteins by 
polyacrylamide gel electrophoresis was as described previously [8]. 
Phosphorylated EF-2, the predominant phosphorylated protein of 
pancreas cytosol, was made visible by autoradiography of the gels 
and could be quantitated by scanning of the autoradiograms or by 
cutting out and counting the piece of the gel containing EF-2. 
2.2.4. Assay of the EF-2 dephosphorylating activity of PPl, and 
PP2Ac 
20 pl of 32P-labelled pancreas cytosol were incubated at 30°C for 
15 min with 20,~l of Tris/EDTA buffer (SO mM Tris-HCl, 1 mM 
EDTA, pH 8.0) and 1 pl of purified PP lc or PPZA, (final concentra- 
tions are given in the text). In some experiments, 1~1 of okadaic acid 
a 100 
PP 2A, 
/ 
PPlC 
b 
in acetone or 1 pl of heparin in Tris/EDTA buffer at various concen- 
trations, as indicated in the text, was added to the incubation mix- 
ture. The reaction was stopped by addition of 10% trichioroacetic 
acid and pelleted proteins were processed for polyacrylamide gel elec- 
trophoreses as described previously [8]. 
3. RESULTS 
Mouse pancreas cytosol was used to prepare 
t’P]EF-2, as previously described [7]. Cytosol proteins 
were phosphorylated with 13’P]ATP, using the en- 
dogenous Ca2+/calmodulin-dependent kinase III. 
Under these conditions EF-2 is one of the most promi- 
nent phosphorylated proteins in pancreas cytosol (see 
figs 1 b, 2 and 171). The phosphorylated cytosol proteins 
were then incubated at 30°C for I5 min with buffer 
alone, with the catalytic subunit of protein phosphatase 
1 (PPl,) or with the catalytic subunit of protein 
phosphatase 2A (PPZA,) at various concentrations. As 
shown in fig.la and b, PP2A, exhibited strong 
EF-2-dephosphorylating activity at a concentration 
around 0.8 U/ml. PPl, was unable to dephosphorylate 
EF-2 even at a 2 times higher concentration (1.8 U/ml) 
and at 5.5 U/ml it caused not more than 25% 
dephosphorylation of EF-2 (fig. la). It can be estimated 
that in order to obtain 50% 32P-release from 
phosphorylated EF-2, around 50 times more PP1, than 
PP2A, would be required. At the concentrations used, 
PP2Ac did not release any 32P from other cytosol pro- 
teins than EF-2 (fig.lb). When we used phosphorylated 
C 
1 2 5.5 
PPZA=tU/ml) - 0.16 0.79 1.58 PP2A~(U/rnl} - - 1.58 
Enzyme concentration [U/ml] PPl, (U/ml) - 1.85 - 
Fig.1. Dephosphorylation of phosphorylated EF-2 with PPl, and PPZA,. One unit of phosphatase activity is defined as 1 nmol phosphate 
liberated per minute under the assay conditions (see section 2). (a) Phosphorylated proteins of mouse pancreas cytosol containing EF-2 were 
incubated at 30°C for 15 min with buffer alone, with purified PPL or PPZA, at the indicated concentrations and separated by gel etectrophoresis. 
For the experimental details see section 2. The EF-2 bands were cut out of the gel and the radioactivity measured. “P-release from EF-2 is given 
in percent (incubation with buffer alone = 0%). Each value represents the mean of 2 experiments. (+--a ) PP2A,; (bd) PPl,. (b) 
Phosphorylated cytosol proteins were incubated with various concentrations of PP2A, as in (a), separated by gel electrophoresis and made visible 
by autoradiography (see section 2; EF-2 is indicated by an arrow). (c) Phospho~iated proteins of mouse spleen cytosol were incubated with buffer 
alone, with 1.58 U/ml of PP2A, or 1.85 U/ml of PPI, and processed as in (b). EF-2 is indicated by an arrow. 
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Fig.2. Inhibition of PPZA,-catalyzed EF-2 dephosphorylation by 
okadaic acid. Phosphorylated proteins of pancreas cytosol were 
incubated with 1.58 U/ml of PPZA, as in fig.la. 1 ~1 okadaic acid 
dissolved in acetone was added at the indicated final concentrations 
simultaneously with PPZA,. 1~1 acetone was added to the control 
incubation with PP2A, alone. Precipitated proteins were separated 
by gel electrophoresis and made visible by autoradiography (see 
section 2; EF-2 is indicated by an arrow). 
OcA(M)- - 1tY7 10-g 1O-g 
Fig.3. Inhibition of EF-2 phosphatase by okadaic acid in epidermal 
cytosol of TPA-treated mice. TPA (10 nmol) was applied topically to 
mouse skin and after 17 h epidermal cytosol was prepared. Pancreas 
cytosol containing phosphorylated EF-2 was mixed with the 
epidermal cytosol (TEC) and incubated at 30°C for 15 min with and 
without okadaic acid (OcA) at the indicated concentrations. After 
precipitation by 10% trichloroacetic acid, the phosphorylated 
proteins were separated by gel electrophoresis. For the details of the 
procedure see section 2 and [7,8]. EF-2 is indicated by an arrow. 
m- - - - t t 
Hep - - t + 
Fig.4. Inability of heparin to suppress PP2A,-catalyzed EF-2 
dephosphorylation as well as the EF-2 phosphatase in epidermal 
cytosol of TPA-treated mice. The experiments were performed as 
described in figs 2 and 3, respectively, except that 50 fig/ml heparin 
(Hep) in Tris/EDTA buffer instead of okadaic acid was added to the 
incubation mixture. Therefore, just the EF-2 band of the 
autoradiogram is shown. 
cytosol proteins from mouse spleen, again PP2A, 
(1.58 U/ml) released 32 P just from EF-2 and PPl, 
(1.85 U/ml) was totally inactive (fig.lc). 
PP%&-catalyzed EF-2 dephosphorylation in mouse 
pancreas cytosol could be inhibited completely by 10e7 
and 10m8 M okadaic acid, by adding okadaic acid 
simultaneously with PP2A, to the cell-free system 
(fig.2). 
As reported previously [7], topical application of the 
phorbol ester TPA to mouse skin strongly increased the 
activity of an EF-2 phosphatase in epidermal cytosol. 
After incubation of phosphorylated cytosol proteins of 
mouse pancreas with epidermal cytosol of TPA-treated 
mice, 32P was released from phosphorylated EF-2 (see 
[7] and fig.3). Addition of okadaic acid to this incuba- 
tion mixture at the final concentration of low7 and 
lo-’ M suppressed the 32P-release from EF-2 complete- 
ly. With 10m9 M okadaic acid still weak inhibition of 
EF-2 dephosphorylation was observed (fig.3). Heparin 
(50 ,ug/ml) neither inhibited EF-2 dephosphorylation 
by the purified PP2A, nor EF-2 dephosphorylation by 
epidermal cytosol of TPA-treated mice (fig.4). Heparin 
(up to 600pg/ml) was ineffective in this respect (data 
not shown). 
4. DISCUSSION 
Activation of EF-2 by its dephosphorylation might 
be one crucial process in the regulation of protein 
biosynthesis [2,6,7]. Therefore, the nature of the 
respective protein phosphatase is of great interest. 
Topical application of the phorbol ester TPA to mouse 
skin induces an increase in the activity of an EF-2 
phosphatase in epidermal cytosol [7]. This protein 
phosphatase has M, 38000 which would be in accor- 
dance with the molecular mass of the catalytic subunit 
of a type 1 or type 2A phosphatase .[7]. The purified 
catalytic subunit of type 2A phosphatases (PPZA,) is 
around 50 times more active in the dephosphorylation 
of EF-2 than that of type 1 phosphatases (PPl,). This 
shows, at least in vitro, a preference of phosphorylated 
EF-2 for PP2A, and can be taken as a first indication 
for the TPA-stimulated EF-2 phosphatase being a type 
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2A rather than a type 1 phosphatase. Furthermore, at 
the low concentrations used, PP2A, appears to be 
highly specific for EF-2, since no other cytosol proteins 
are dephosphorylated. 
Recently, okadaic acid was reported to inhibit 
various types of protein phosphatases to a different ex- 
tent 1111. According to this report, lo-* M okadaic 
acid caused more than 80% suppression of PP2A, ac- 
tivity, but almost no suppression of PPl, activity with 
phosphorylase a or myosin light chain as substrates. In 
our hands, PP2A, shows the same high sensitivity 
towards okadaic acid with EF-2 as a substrate. The 
TPA-stimulated EF-2 phosphatase in epidermal cytosol 
can be inhibited completely by IO-’ M okadaic acid, in- 
dicating the identity of its catalytic subunit with 
PP2A,. 
Heparin is known to be a strong inhibitor of PPl 
(Ki = 8 lug/ml [12,13]). According to Gergely et al. 
[ 121, heparin up to 50 pg/ml does not suppress PP2 ac- 
tivity. We tested heparin at concentrations up to 
600 yg/ml and did not observe any inhibition of PP2A, 
activity with EF-2 as a substrate. The TPA-stimulated 
EF-2 phosphatase in epidermal cytosol is also not in- 
hibited by heparin at concentrations up to 600 sg/ml. 
Thus, in accordance with the other results, we can ex- 
clude that it is a type 1 phosphatase. 
Taken the results together, the high EF-2 
dephosphorylating activity of PP2A, in vitro, the 
molecular weight of the TPA-stimulated EF-2 
phosphatase [7], its sensitivity towards okadaic acid 
and its insensitivity towards heparin, we can conclude 
that most likely TPA stimulates a type 2A protein 
phosphatase in mouse epidermis, which plays a major 
role in the dephosphorylation of EF-2 in vivo and thus 
in the regulation of protein synthesis. The mechanism 
by which TPA stimulates the EF-2 phosphatase of the 
2A type is presently under investigation. 
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